Global Transplantation Market Insights Forecasts to 2032

• The Global Transplantation Market Size was valued at USD 8.5 Billion in 2022.
• The Market is Growing at a CAGR of 9.5% from 2022 to 2032
• The Worldwide Transplantation Market Size is expected to reach USD 21.2 Billion by 2032
• Asia Pacific is expected to grow the fastest during the forecast period

The Global Transplantation Market Size is expected to reach USD 21.2 Billion by 2032, at a CAGR of 9.5% during the forecast period 2022 to 2032.

Transplantation is a surgical procedure that involves implanting an organ or living tissue in another part of the body or another body. The rising demand for these procedures and the launches of new products designed to prevent the failure of these procedures are some of the main drivers contributing to transplantation market growth during the forecast period. Organ failure is typically caused by a combination of factors such as severe trauma, blood loss, poisoning, drug abuse, leukemia, sepsis, and other acute diseases. This is anticipated to increase demand for transplantation products in the coming years. The demand for organ and tissue transplantation, particularly for the heart, kidney, lungs, and liver, is extremely high. Moreover, various non-governmental and government organizations are assisting in increasing awareness about the importance of organ donation.

Driving Factors

A significant rise in these procedures globally due to organ demand will most likely drive overall market growth during the forecast period. Chronic diseases such as cancer, kidney failure, COPD, and lupus are becoming more common, which frequently results in extensive tissue and organ damage. One of the most important factors influencing market growth is the increase in organ failures. Furthermore, emerging and developed countries, such as the United States and the United Kingdom, are constantly raising public awareness about organ donation. The focus on developed healthcare infrastructure and the implementation of favorable reimbursement policies are driving market growth during the forecast period. Autologous stem cell transplant, which has become more convenient with the advent of induced Pluripotent Stem Cells (iPSC), is one of the emerging technologies in tissue products. The development of technologically advanced tissue products is expected to be one of the distinguishing factors driving market growth over the forecast period.

Restraining Factors        

Some factors, such as the lack of organ donors for transplantation procedures, are expected to limit market growth during the forecast period. There is a significant shortage of organs for the treatment of organ failure. There is a high probability of transplant rejection. Despite donor matching, tissue typing, and the use of immunosuppressants, transplants are sometimes rejected by an individual's body, resulting in organ failure.

Market Segmentation

By Product Type Insights

The tissue product segment is expected to hold the largest share of the global transplantation market during the forecast period.

Based on the product type, the global transplantation market is classified into tissue products, immunosuppressive drugs, and preservation solutions. Among these, the tissue product is expected to hold the largest share of the transplantation market during the forecast period. The growth can be attributed due to increased R&D initiatives by various medical device companies leading to product launches. Also, a rising amount of trauma and injury cases drives the segmental growth. The growing number of transplantation procedures, such as cochlear, heart valve, bone marrow, and orthopedic soft tissues, is attributed to the segment's expansion. Furthermore, new product development drives market growth during the forecast period.

By Application Insights

The tissue transplantation segment is witnessing significant CAGR growth over the forecast period.

Based on the application, the transplantation market is segmented into organ transplantation and tissue transplantation. Among these, the tissue transplantation segment holds the significant CAGR growth over the forecast period. This is due to skin, cornea, bones, heart valves, tendons, nerves, and veins replacement are the most commonly performed procedures globally. The increasing number of burn and accident cases is expected to drive tissue product demand.

By End User Insights

The transplantation center segment is witnessing substantial CAGR growth over the forecast period.

Based on the end user, the transplantation market is segmented into hospitals, transplantation centers, and others. Among these, the transplantation center segment is dominating the market with substantial CAGR growth over the forecast period. The reason behind the growth is the increasing demand for advanced healthcare centers as the demand for transplantation procedures rises, and transplant centers being an ideal option for older adults as it provides personalized care and avoids frequent hospital visits. In addition, treatment in transplant centers reduces the risk of hospital-acquired infections.

Regional Insights

North America dominates the market with the largest market share over the forecast period.

North America is dominating the market share over the forecast period, due to the high demand for unique tissue transplantation products and organ transplantation, the market is anticipated to stay dominant. Other factors that contributed to market development include favorable reimbursement plans and the rapid adoption of three-dimensional (3D) bioprinting across the region. Furthermore, the presence of prominent companies in the United States, as well as regulatory approvals for innovative items, are some common contributing factors to North American market growth during the forecast period. The presence of many large biotechnology and medical device companies, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker, as well as well-developed healthcare facilities, contribute to market growth during the forecast period.

The Asia Pacific market is expected to grow at the fastest rate during the forecast period. The rising prevalence of various chronic diseases, as well as the increasing incidence of road accidents, are causing permanent damage to organs, necessitating the replacement of damaged organs with healthy organs to save the patient's life, which are major factors driving revenue growth in the Asia Pacific region. Additionally, continuous advancements in transplantation technology by major players in the Asia Pacific region are driving the transplantation market.

List of Key Market Players

• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Arthrex, Inc.
• Veloxis Pharmaceuticals, Inc.
• BioLife Solutions
• TransMedics
• F. Hoffmann-La Roche Ltd
• Zimmer Biomet
• Astellas Pharma Inc.
• Abbvie, Inc
• Medtronic
• Strykers
• 21st Century Medicine

Key Market Developments

• In January 2022, Novartis AG partnered with Alnylam to investigate targeted therapy to restore liver function. Alnylam's siRNA technology is intended to promote the regrowth of functional liver cells and is an option for patients suffering from liver failure.

• In January 2022, BioLife Solutions and Seattle Children's Therapeutics expanded their collaboration to optimize biopreservation and closed-system manufacturing by integrating Sexton's AF-500 cell processing tools.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the global transplantation market based on the below-mentioned segments:

Transplantation Market, Product Type Analysis

• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions

Transplantation Market, Application Analysis

• Organ Transplantation
• Tissue Transplantation

Transplantation Market, End User Analysis

• Academic Medical Institutes
• Pharmaceutical & Biotechnology Companies

Transplantation Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa